Literature DB >> 6593107

Neuropeptide Y potentiates the effect of various vasoconstrictor agents on rabbit blood vessels.

L Edvinsson, E Ekblad, R Håkanson, C Wahlestedt.   

Abstract

The contractile effect of neuropeptide Y (NPY) was tested on isolated segments of basilar artery, central ear artery, gastro-epiploic artery and vein, and femoral artery and vein from the rabbit. At 30 nM NPY did not evoke vasoconstriction; at 300 nM NPY evoked a weak and variable response. NPY greatly potentiated the response of the gastro-epiploic and femoral arteries to noradrenaline without affecting the maximum response. As tested on the gastro-epiploic artery NPY was effective at concentrations of 1 nM and higher. As tested on the femoral artery the potentiating effect of 30 nM NPY on noradrenaline-evoked contractions was apparent immediately and 30 min after the application of NPY, but not after one hour. NPY (30 nM) potentiated the contractile response to noradrenaline and histamine but not to 5-hydroxytryptamine or high K+. The response to histamine was augmented in both arteries and veins, whereas the response to noradrenaline was enhanced in arteries but not in veins. NPY failed to potentiate the prostaglandin F2 alpha-evoked contraction except in the gastro-epiploic vein.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6593107      PMCID: PMC1987132          DOI: 10.1111/j.1476-5381.1984.tb16516.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  8 in total

Review 1.  Mechanisms of action of transmitters and other substances on smooth muscle.

Authors:  T B Bolton
Journal:  Physiol Rev       Date:  1979-07       Impact factor: 37.312

2.  Pancreatic polypeptide family (APP, BPP, NPY and PYY) in relation to sympathetic vasoconstriction resistant to alpha-adrenoceptor blockade.

Authors:  J M Lundberg; K Tatemoto
Journal:  Acta Physiol Scand       Date:  1982-12

3.  Neuropeptide Y in vitro selectivity increases the number of alpha 2-adrenergic binding sites in membranes of the medulla oblongata of the rat.

Authors:  L F Agnati; K Fuxe; F Benfenati; N Battistini; A Härfstrand; K Tatemoto; T Hökfelt; V Mutt
Journal:  Acta Physiol Scand       Date:  1983-07

4.  Neuropeptide Y--a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide.

Authors:  K Tatemoto; M Carlquist; V Mutt
Journal:  Nature       Date:  1982-04-15       Impact factor: 49.962

5.  Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function.

Authors:  J M Lundberg; L Terenius; T Hökfelt; C R Martling; K Tatemoto; V Mutt; J Polak; S Bloom; M Goldstein
Journal:  Acta Physiol Scand       Date:  1982-12

6.  Neuropeptide Y: complete amino acid sequence of the brain peptide.

Authors:  K Tatemoto
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

7.  Neuropeptide Y: cerebrovascular innervation and vasomotor effects in the cat.

Authors:  L Edvinsson; P Emson; J McCulloch; K Tatemoto; R Uddman
Journal:  Neurosci Lett       Date:  1983-12-23       Impact factor: 3.046

8.  Neuropeptide Y (NPY) reduces myocardial perfusion and inhibits the force of contraction of the isolated perfused rabbit heart.

Authors:  J M Allen; P M Bircham; A V Edwards; K Tatemoto; S R Bloom
Journal:  Regul Pept       Date:  1983-07
  8 in total
  60 in total

1.  Pharmacology of the coronary circulation.

Authors:  J C Sill
Journal:  Can J Anaesth       Date:  1987-05       Impact factor: 5.063

Review 2.  Sympathetic control of reflex cutaneous vasoconstriction in human aging.

Authors:  Jody L Greaney; Lacy M Alexander; W Larry Kenney
Journal:  J Appl Physiol (1985)       Date:  2015-08-13

3.  Presynaptic action of neuropeptide Y in area CA1 of the rat hippocampal slice.

Authors:  W F Colmers; K Lukowiak; Q J Pittman
Journal:  J Physiol       Date:  1987-02       Impact factor: 5.182

Review 4.  The role of neuropeptides in cardiovascular regulation.

Authors:  D Ganten; M Paul; R E Lang
Journal:  Cardiovasc Drugs Ther       Date:  1991-02       Impact factor: 3.727

5.  Fetal cardiovascular, metabolic and endocrine responses to acute hypoxaemia during and following maternal treatment with dexamethasone in sheep.

Authors:  J K Jellyman; D S Gardner; C M B Edwards; A L Fowden; D A Giussani
Journal:  J Physiol       Date:  2005-06-23       Impact factor: 5.182

6.  PYY-like material and its spatial relationship with NPY, CGRP and 5-HT in the lung of the Syrian golden hamster.

Authors:  I M Keith; R Ekman
Journal:  Cell Tissue Res       Date:  1990-12       Impact factor: 5.249

7.  Remodeling of stellate ganglion neurons after spatially targeted myocardial infarction: Neuropeptide and morphologic changes.

Authors:  Olujimi A Ajijola; Daigo Yagishita; Naveen K Reddy; Kentaro Yamakawa; Marmar Vaseghi; Anthony M Downs; Donald B Hoover; Jeffrey L Ardell; Kalyanam Shivkumar
Journal:  Heart Rhythm       Date:  2015-01-30       Impact factor: 6.343

8.  Inhibition of neuropeptide Y-induced potentiation of noradrenaline-induced vasoconstriction by PP56 (D-myo-inositol 1,2,6-tris-phosphate).

Authors:  M Adamsson; B Fallgren; L Edvinsson
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

9.  Fish oil diet rich in eicosapentaenoic acid increases bleeding time in the rat by interaction with sympathetic transmitters.

Authors:  H Juan; W Sametz
Journal:  Agents Actions       Date:  1989-08

10.  The ability of neuropeptide Y to mediate responses in the murine cutaneous microvasculature: an analysis of the contribution of Y1 and Y2 receptors.

Authors:  Duc Quyen Chu; Helen M Cox; Soraia K P Costa; Herbert Herzog; Susan D Brain
Journal:  Br J Pharmacol       Date:  2003-08-26       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.